期刊文献+

他汀类药物在肺疾病中的临床研究进展

暂未订购
导出
摘要 他汀类药物是20世纪80年代后期开发的羟甲戊二酰辅酶A(HMG-CoA)还原酶抑制剂。HMG-CoA还原酶是胆固醇合成酶系中的限速酶,他汀类药物通过对其抑制作用,使胆固醇的合成减少,使血浆和组织细胞内胆固醇浓度均降低,促进浓度依赖的低密度脂蛋白(LDL)受体活性提高,加速LDL的分解代谢,所以,它能够降低心血管疾病[1]和脑卒中[2]患者的病死率和致残率。同时,他汀类药物能够调节炎症过程,抑制炎症细胞因子、趋化因子和黏附分子的表达,降低C-反应蛋白(CRP)的水平,本文将着重介绍它的抗炎特性。
作者 吕秀英
出处 《现代医药卫生》 2012年第6期891-892,共2页 Journal of Modern Medicine & Health
  • 相关文献

参考文献13

  • 1LaRosa JC,He J,Vupputuri S.Effect of statins on risk of coronary dis-ease:a metaanalysis of randomized controlled trials[J].JAMA,1999,282(24):2340-2346.
  • 2Briel M,Studer M,Glass TR,et al.Effects of statins on stroke preventionin patients with and without coronary heart disease:a meta-analysis ofrandomized controlled trials[J].Am J Med,2004,117(8):596-606.
  • 3Lee JH,Lee DS,Kim EK,et al.Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs[J].Am JRespir Crit Care Med,2005,172(8):987-993.
  • 4Turner NA,O’Regan DJ,Ball SG,et al.Simvastain inhibits MMP-9 se-cretion from human saphenous vein smooth musele cells by inhibiting theRhoA/ROCK pathway and reducing MMP-9 mRNA levels[J].FASEB J,2005,19(7):804-806.
  • 5庞国强.他汀类药物的药理与临床应用[J].中国医药导报,2010,7(1):11-12. 被引量:20
  • 6McCarey DW,Mclunes IB,Madhok R,et al.Trial of Atorvastatin inRheumatoid Arthritis(TARA):double-blind,randomised placebo-con-trolled trial[J].Lancet,2004,363(9426):2015-2021.
  • 7Barnes PJ,Chung KF,Page CP.Inflammatory mediators of asthma:an up-date[J].Pharmacol Rev,1998,50(4):515-596.
  • 8王立,吴昌归,倪殿涛,陈宏谦.氟伐他汀对哮喘大鼠气道重建的影响及其机制[J].第四军医大学学报,2007,28(7):637-640. 被引量:4
  • 9徐宜全,王红.辛伐他汀对支气管哮喘干预作用的研究现状[J].中国综合临床,2009,25(4):440-441. 被引量:2
  • 10Alexeeff SE,Litonjua AA,Sparrow D,et al.Statin use reduces decline inlung function:VA Normative Aging Study[J].Am J Respir Crit Care Med,2007,176(8):742-747.

二级参考文献34

  • 1赵峰,戚好文,叶江枫,赵一岭.氟伐他汀对大鼠肺纤维化的治疗作用[J].解放军医学杂志,2004,29(8):703-706. 被引量:8
  • 2王文建,杨莉,王西华,李海浪.川芎嗪对大鼠支气管哮喘模型气道重塑的影响及机制[J].中华结核和呼吸杂志,2004,27(12):833-836. 被引量:73
  • 3赵玉兰,程劲松,杨树涵.辛伐他汀对慢性心衰大鼠心肌纤维化及TGF-β_1 CTGF表达的影响[J].医药论坛杂志,2006,27(24):7-9. 被引量:7
  • 4李文红.HMG-COA还原酶抑制剂对预防痴呆有帮助.国外医学:内科学分册,2001,28(4):154-154.
  • 5Fixman ED, Stewart A, Martin JG. Basic mechanisms of development of airway structural changes in asthma [ J ]. Eur Respir J, 2007,29 (2) :379-389.
  • 6Trivedi SG, Lloyd CM. Eosinophils in the pathogenesis of allergic airways disease[J]. Cell Mol Life Sci,2007,64(10) :1269-1289.
  • 7Rosenberg HF, Phipps S, Foster PS. Eosinophil trafficking in allergy and asthma [ J ]. J Allergy Clin Immunol, 2007,119 ( 6 ) : 1303- 1310.
  • 8Boxall C, Holgate ST, Davies DE. The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma[ J]. Eur Respir J,2006,27( 1 ) :208- 229.
  • 9Waiters EH, Sohani A, Reid DW, et al. Vascular remodelling in asthma[ J ]. Curt Opin Allergy Clin Immunol,2008,8 (1) :39-43.
  • 10Abeles AM, Pillinger MH. Statins as antiinflammatory and immunomodulatory agents: a future in rheumatologic therapy [ J ]? Arthritis Rheum, 2006,54 ( 2 ) : 393 -407.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部